Gregory Katz is the ESSEC-sanofi-aventis Chaired Professor of Therapeutic Innovation at ESSEC Business School (Paris, Singapore). He holds a Doctorate in Philosophy (Université Paris-Sorbonne), a Doctorate in Biopharmaceutical Sciences (Université Paris-Descartes) and a Master of Business Admninistration (ESSEC Business School).
His research activities focus on the socio-economic impact of regenerative medicine, biobanking, intellectual property in lifesciences, orphan drugs, pharmacogenomics, and the development of genetic testing. In 2002, he published "Le Chiffre de la vie: réconcilier la génétique et l’humanisme" (Editions du Seuil). Prefaced by Nobel laureate Elie Wiesel, a revised edition will be translated in Italian (Ed. Cantagalli, 2008) and in English (Yale University Press, 2009). Gregory Katz has been teaching business ethics as a visiting professor at INSEAD (Fontainebleau, Singapore).
He is teaching Bioethics as a visiting professor at Bocconi University SDA (Milan). He was deputy director of the Bioethics Advisory Committee of the French Israelite Consistory. He was the co-founder and the vice president of the Eurocord Association, an international platform specialized on cord blood stem cells research. He is a member of several editorial boards of academic journals including Philosophy of Management and the International Journal of Pharmaceutical and Healthcare Marketing. He was the 2008 Laureate of the San Benedetto Prize awarded by the Fondazione Sublacense for his work on bioethics and humanism.